Your browser doesn't support javascript.
loading
Lupus Cerebritis Refractory to Guideline-Directed Therapy: A Case Report.
Rao, Suman; Sunkara, Akhila; Ashwath, Ashwini; Srivastava, Nimisha; Albert, Emily.
Afiliação
  • Rao S; SUNY Upstate Medical University, Syracuse, NY, USA.
  • Sunkara A; SUNY Upstate Medical University, Syracuse, NY, USA.
  • Ashwath A; SUNY Upstate Medical University, Syracuse, NY, USA.
  • Srivastava N; SUNY Upstate Medical University, Syracuse, NY, USA.
  • Albert E; SUNY Upstate Medical University, Syracuse, NY, USA.
J Investig Med High Impact Case Rep ; 9: 23247096211008708, 2021.
Article em En | MEDLINE | ID: mdl-33843326
ABSTRACT
Systemic lupus erythematosus is an autoimmune disease that affects multiple organs and organ systems, subsequently requiring an elaborate regimen for management. We present the case of a 63-year-old female who developed unrelenting symptoms of drug-induced lupus, which persisted even after the offending agent was withdrawn, unmasking her underlying systemic lupus erythematosus. She continued to develop neuropsychiatric symptoms, including mania and hallucinations, which complicated the management of her disease. After exhausting the bank of anti-inflammatory and immunomodulators recommended by current guidelines, we found that a combination of rituximab infusions with thiothixene, an antipsychotic agent, significantly improved our patient's neuropsychiatric symptoms. Further research should be conducted to determine the efficacy of rituximab in the treatment of resistant lupus cerebritis, and to validate the use of thiothixene in the management of neuropsychiatric symptoms secondary to lupus.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiotixeno / Rituximab / Lúpus Eritematoso Sistêmico / Meningite Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Revista: J Investig Med High Impact Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiotixeno / Rituximab / Lúpus Eritematoso Sistêmico / Meningite Tipo de estudo: Guideline Limite: Female / Humans / Middle aged Idioma: En Revista: J Investig Med High Impact Case Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos